Dkk-1 Polyclonal Antibody

DKK1 encodes dickkopf WNT signaling pathway inhibitor 1 that is a member of the dickkopf family. It is a secreted protein with two cysteine rich regions and is involved in embryonic development through its inhibition of the WNT signaling pathway. Elevated levels of DKK1 in bone marrow plasma and peripheral blood is associated with the presence of osteolytic bone lesions in patients with multiple myeloma.

The Dkk-1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Dkk-1 protein in various biological samples. This antibody has been meticulously developed and rigorously validated to ensure optimal performance and reliability.

With its exceptional affinity and selectivity, the Dkk-1 Polyclonal Antibody offers unparalleled accuracy and precision in Dkk-1 protein analysis. It exhibits minimal cross-reactivity with other proteins, guaranteeing reliable and reproducible results.

This antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to ensure batch-to-batch consistency and superior performance. It is produced in a GMP-compliant facility, adhering to the highest industry standards.

The Dkk-1 Polyclonal Antibody is suitable for a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA). It is compatible with various sample types, including cell lysates, tissue homogenates, and serum.

Furthermore, this antibody is provided in a convenient and user-friendly format, allowing for easy handling and storage. It is supplied as a liquid formulation, eliminating the need for reconstitution and ensuring immediate usability.

In summary, the Dkk-1 Polyclonal Antibody is a reliable and efficient tool for the accurate detection and quantification of Dkk-1 protein. Its exceptional specificity, sensitivity, and ease of use make it an invaluable asset for researchers and scientists in the field of molecular biology and biomedical research.